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Abstract
Objecti ves: To determine the rate of admission to an Obstetrical Intensive Care Unit 
(O-ICU), maternal mortality rate and the main factors associated with it.
Methods: This was a retrospecti ve study, analyzing all the admission to an O-ICU between 
January 1, 2009, and November 28, 2016. The registries were completed since the fi rst 
day of recruitment unti l discharge or death.
Results: Among 2,145 pati ents admitt ed to the O-ICU during the study period, maternal 
mortality was of 4.6% (n = 100). The three main causes of hospitalizati on were hypertensive 
disorders (47.1%), bleeding disorders (18.9%) and infecti ous complicati ons (5.4%). The 
Receiver Operati ng Characteristi c (ROC) curve showed the pati ent’s age was the variable 
with the largest area under the curve (0.569) in relati on to mortality. Applying the linear 
regression model gave as a result that age, Mean Arterial Pressure (MAP), platelets at 
admission and haemoglobin are signifi cant (P ≤ 0.001) as predicti ve factors for mortality. 
The Weight Esti mati on test also showed signifi cance for platelets count and MAP at 
admission.
Conclusion: From the analysis done, it showed that the pati ent’s age, MAP and platelets 
at admission are the most important parameters to predict mortality. 
Introducti on
 Obstetric morbidity and mortality have been a problem of great interest due to 
its social and economic impact during the past decades. Even more, the actual changes in 
obstetric practi ce because of the pati ents’ age, and an increase of chronic comorbiditi es 
have increased the need of criti cal medical care because of pregnancy or delivery 
associated complicati ons. 
 The admission of a pregnant woman into an Obstetric Intensive Care Unit (O-ICU) 
is a challenge for the health team. The mortality of such pati ents is variable, ranging from 
0 to 40% depending mainly on the development of each country1. In this regard, the 
Maternal Mortality Rate (MMR) has been used as an important indicator of the health 
system’s performance and is indirectly related to the populati on’s sanitary conditi ons2.
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 According to the World’s Health Organizati on (WHO), improving maternal health 
should be att ained around the world, as established in the Sustainable Development Goals 
(SDG)3. Stated also by the WHO, obstetric mortality is defi ned as “the death of a woman 
while pregnant or within 42 days of terminati on of pregnancy, irrespecti ve of the durati on 
and site of the pregnancy, from any cause related to or aggravated by the pregnancy or 
its management but not from accidental or incidental causes”4. Moreover, as sett led in 
the SDG, it is a priority to decrease MMR to 70 per 100,000 live births, by 2030. Not 
withstanding, in developing countries such as Mexico, the MMR remains as one of the 
main health system challenges. 
 Unfortunately, the main causes of death among pregnant woman conti nue as 
preventable complicati ons, which must be averted to achieve this goal. In this matt er, 
the prevalence of maternal mortality has decreased signifi cantly in the past decade in 
the State of Mexico, Mexico around 50%, as shown in the most recent inform5. Even so, 
the MMR is sti ll very high, which enhances the necessity of determining the main causes, 
course and outcome of obstetric admissions in specialized maternal and perinatal centres. 
 The objecti ve of this study was to determine an epidemiological profi le and 
potenti al trends on the admissions into an O-ICU describing the main complicati ons and 
factors associated to maternal mortality in a third level Hospital in a developing Country.
Methods
 This was a retrospecti ve descripti ve study, performed at the “Mónica Pretelini 
Sáenz” Maternal-Perinatal Hospital (HMPMPS), Health Insti tute of the State of Mexico 
(ISEM), Toluca, Mexico, between January 1, 2009, and November 28, 2016. 
 Clinical data were collected by doctors in an Excel sheet designed for this survey. 
The registries were completed since the fi rst day of recruitment unti l discharge or death. 
Procedure
 As a rule, candidate pati ents to be admitt ed to the O-ICU were considered based 
on the Priority model (Table 1). Data were collected on pati ent age; number of days at 
the hospital; existence of diseases prior to pregnancy; city and hospital of origin; parity; 
stage of pregnancy on admission; primary cause of hospitalizati on; clinical complicati ons 
such as the need for anti bioti cs, mechanical venti lati on, or haemodialysis; and maternal 
survival unti l discharge from the O-ICU or death. The primary cause of admission to the 
O-ICU was classifi ed as direct or indirect obstetric, or non-obstetric. WHO criteria were 
used to classify maternal death. 
Laboratory studies
 The laboratory tests registered in the Medical File from each pati ent were 
processed at the Clinical Laboratory of the HMPMP according to standardized procedures 
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recommended by the Internati onal Federati on of Clinical Chemistry and Laboratory 
Medicine (IFCC).
Stati sti cal analysis
 Results were presented as mean ± standard error (SD) for conti nuous variables 
and in percentages for qualitati ve ones. Relati onships between the quanti tati ve measured 
variables (Hb, platelets and mean arterial pressure (MAP) on admission and Hb, platelets 
and albumin on delivery) were assessed using Pearson correlati ons. The Receiver Ope-
rati ng Characteristi c (ROC) curve and the Cox regression test were used to determine a 
possible signifi cance of mortality predicti on with the clinical and Laboratory variables. 
Finally, the multi nomial logisti c regression was used to analyze the variable “dialysis” 
or “use of amines” as predictors of mortality. Signifi cance was set at P < 0.05. All tests 
were performed with the SPSS version 23 stati sti cal soft ware program (IBM SPSS Stati sti cs 
Armonk, NY: IBM Corp.).
Ethics
 The study was approved by the Research Committ ee and the Ethics on Research 
Committ ee of the HMPMPS (code 2018-04-580). The process complied with the ethical 
principles of the Declarati on of Helsinki (Fortaleza, Brazil), and writt en informed consent 
was waived as this was a retrospecti ve study.
Results
 Since the opening of the O-ICU on April 1, 2009, unti l December 31, 2016, 2,145 
pati ents have been treated in criti cal conditi on. This mean an average of 268 pati ents per 
year att ended at the O-ICU. Only 567 pati ents (26.4%) were from the city where this third 
level Hospital is located. During the period of the study, there were 73,625 births with 
an esti mated 29.1 admissions to the O-ICU per 1000 deliveries. Most of the admissions 
(1,534 women, 71.5%) of the cohort study occurred during the postpartum period, and 
22.3% were sti ll pregnant. Four women (0.41%) were transferred to a Nati onal Health 
Insti tuti on (NHI).
 Mean age of the att ended women was of 27.4 years. Four hundred fi ft y-four (21.2%) 
were under 20 years, and 362 (16.9%) were over 35 years. From the full populati on, 1,358 
(63.3%) women were referred from other hospitals or health units, 578 (26.9%) came 
directly from their homes and 209 (9.74%) from other services (Maternal-Fetal Medicine 
Service and Gynecology Service) of the same HMPMPS. Regarding the general cause of 
O-ICU admission, 1,010 (47.1%) were suff ering from Hypertensive Diseases (HPDs), 405 
(18.9%) of bleeding disorders and 115 (5.4%) of infecti ous complicati ons (Table 2). Among 
the 1,010 women suff ering from HPDs, the categories were preeclampsia/eclampsia: 640 
(63.4%) and HELLP (haemolysis, elevated liver enzymes, low platelet count) syndrome: 
370 (36.6%). 
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Criti cal, unstable pati ents with potenti ally reversible conditi ons requiring intensive 
therapy (venti latory support, vasoacti ve drugs), close and conti nuous observati on. 
When reversibility and / or prognosis are uncertain, a limited therapeuti c trial ti me 
can be given in the O-ICU. This category excludes pati ents with underlying chronic 
diseases and terminal pati ents.
I a) Unstable pati ents requiring monitoring and / or treatment that can not be 
      provided outside the ICU, 
b)  Pati ents requiring mechanical venti lati on and vasoacti ve drugs, 
c)  Pati ents with shock, post-operati ve and Acute Renal Failure
II a)  Pati ents requiring intensive monitoring and may require immediate interventi on, 
b)  Pati ents with previous comorbid conditi ons who develop acute events.
III a) Unstable pati ents, criti cally ill but who have reduced chances of recovery due to  
 the underlying disease or the acute conditi on of the moment and can benefi t  
 from treatment in the ICU, 
b)  They may receive intensive treatment to alleviate the acute complicati on, however,  
 no extraordinary measures of support will be given as: cardiopulmonary 
 resuscitati on, endotracheal incubati on, mechanical assisted venti lati on, 
 haemodialysis or high cost medicati on. Example of these: pati ents with cancer and  
 superinfecti ons.
IV a)  Pati ents who are generally not appropriate to admit to the ICU. Admission must  
 be individualized under unusual and individualized circumstances under the 
 supervision of the att ending physician, intensivist or Chief of ICU, 
b)  Litt le or no benefi t from a low-risk interventi on. "Too good to benefi t from the ICU", 
c)  Pati ents with terminal illness or imminent death. "Too sick to benefi t from the ICU."
Low 
priority
a) This category includes pati ents at risk of requiring intensive therapy and pati ents  
 with severe, irreversible and disabling medical conditi ons, 
b) Pati ents with chronic, irreversible or terminal illnesses who have suff ered a 
 catastrophic injury should be admitt ed only if there is opportunity for the pati ent to  
 benefi t from aggressive ICU management and if the pati ent and / or family 
 members are prepared to accept the consequences of the necessary therapy.
Table 2. General characteristi cs of the pati ents
Variable Value
Age (years)a 27.4 (± 9.4)
Mean arterial pressure (mmHg)a 90.9 (± 11.2)
Primary admission cause 
Hypertensive disordersb 1,010 (47.08%)
Obstetric haemorrhageb 405 (18.88%)
Infecti ous disordersb 115 (5.36%)
Othersb 615 (28.67%)
Length of stay at the ICU (days)a 5.6 (± 5.9)
Median: 4, ICR: 3
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Use of aminesb 612 (28.53%)
Use of mechanical venti lati onb 695 (32.40%)
Use of anti bioti csb 2,079 (96.92%)
Use of renal replacement therapyb 140 (6.52%)
Blood therapyb 1,265 (58.97%)
Admissions from the same Hospitalb 209 (9.74%)
Admissions from other Hospitalsb 1,358 (63.3%)
        a: mean (± SD), b: frequency (%), IQR: inter quarti le range
 Among the 615 pati ents admitt ed for indirect obstetric causes, 62 (10.1%) had 
heart disease and 56 (3.9%) acute pancreati ti s. Table 3 shows other causes of seeking 
medical att enti on at the O-ICU.
Table 3. Other diseases
Thyrotoxic storm Invasive mole with carcinomatosis
Guillain-Barré Syndrome Diabeti c ketoacidosis and hyperosmolar hyperglycaemic state
Ulcerati ve Coliti s Organophosphosphorus pesti cides poisoning
Cardiomyopathy Systemic Lupus Erythematosus
Pulmonary Oedema Amytrophic Lateral Sclerosis
Liver Abscess Haemorrhages and strokes
Pericarditi s Anti phospholipid syndrome
Leukaemias Collapsed Lung
Liver cirrhosis Acute fatt y liver of pregnancy 
Tamponade Paralysis associated to hypokalemia
Snake bite Myelodysplasti c syndromes
Budd Chiari Syndrome Neurocysti c ercosis
Status epilepti cus Ovarian hypersti mulati on syndrome
Brain tumours Cancer (kidney, lung, stomach)
Leptospirosis Meningiti s and encephaliti s
Cardiac Arrhythmia Mendelson Syndrome
Haemangiomatosis Traumati c brain injury
Haemo mediasti num Haemolysis post transfusion
Phosphine poisoning Suppurati ve Thrombophlebiti s
 In the follow-up period, 100 (4.6%) pati ents died. From these deaths, 63 were 
admitt ed with Priority IV. The percentage of mortality excluding pati ents who entered 
with Priority IV was 1.63%.
 Among the 1,530 women admitt ed for direct obstetric causes, there were 64 
(4.2%) deaths. By contrast, there were 36 (5.8%) deaths among the 615 women admitt ed 
for indirect obstetric causes. By using this approach, the mortality rate among the 1,010 
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women with hypertension complicati ons was 2.9% (30 deaths). Similarly, from 115 women 
admitt ed because of an infecti ous complicati on, 23 (20%) died of septi c shock. In additi on, 
there were 13 (3.2%) deaths in the group who had a haemorrhagic disorder on admission 
(N = 405). In the present context, twenty-fi ve women died from other causes, including 
atypical pneumonia (nine pati ents), massive pulmonary thromboembolism (four pati ents) 
and cardiopathy (six pati ents).
 The length of hospitalizati on varied from a few hours (0 days) to 84 days (mean 5.6 
± 6.0 days; median 4 days). It was also noted that Mechanical Venti latory Support (MVS) 
was used in more than one-third of pati ents (N = 695, 32.4%), with 68,998 hours of use 
and in one case; the Extracorporeal Membrane Oxygenati on (ECMO) was implemented.
 The Pearson test showed the next signifi cant correlati ons: Hb on admission with 
platelets on admission (r2 = 0.065, P = 0.003), Hb on delivery (r2 = 0.467, P ≤ 0.001), albumin 
on delivery (r2 = 0.066, P = 0.003) and MAP (r2 = 0.181, P ≤ 0.001); platelets on admission 
with platelets on delivery (r2 = 0.563, P ≤ 0.001), Hb on delivery (r2 = 0.106, P ≤ 0.001); 
platelets on delivery with Hb on delivery (r2 = 0.093, P ≤ 0.001) and albumin on delivery 
(r2 = 0.139, P ≤ 0.001); Hb on delivery with platelets on delivery (r2 = 0.151, P ≤ 0.001) and 
there were negati ve correlati ons between MAP with platelets on admission (r2 = -0.102, P 
≤ 0.001) and platelets on delivery (r2 = -0.058, P = 0.008).
 The ROC curve taking into account age, Hb on admission, platelets on admission 
and MAP to predict mortality, showed the pati ent’s age as the variable with the largest 
area under the curve (0.569), followed by the MAP (0.423) (Figure 1). 
          Figure (1)
        When constructi ng a model 
with the Cox regression, defi ning the 
“days of stay” as the variable ti me, the 
positi ve status was any case of mortality, 
and the covariates were age, Hb on 
admission, platelets on admission and 
MAP, a signifi cant P value for platelets on 
admission and age (P = 0.010 and 0.026 
respecti vely) was found. When doing 
this same model adding as strata the 
category of “dialysis treatment”, the two 
covariates platelets on admission and 
age were signifi cant (P = 0.039 and 0.029 
respecti vely). Finally, when analyzing 
the variable “dialysis” or “use of amines” with multi nomial logisti c regression both were 
signifi cant as predictors of mortality (P ≤ 0.001).
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Discussion
 The present study reports the fi nding of a terti ary obstetrical ICU; where over 70% 
of the pati ents were referred from a diff erent hospital or healthcare facility. The incidence 
of 29.3 admissions per 1000 deliveries in this study was similar to the rate from a Brazilian 
study2, being up to 16 ti mes higher than the rate of developed countries6. 
 This study further establishes a role for the main fi ndings concerning the O-ICU 
admissions which contrasted with the results from other countries (Table 4). As expected, 
the incidence varies signifi cantly between developed and developing countries, with rates 
reported from 1.3 up to 24 ICU admissions per 1000 deliveries. It can be seen that the rate 
of admission to therapy for each pregnancy was similar to that reported by Brazil2, aft er 
making the adjustment excluding the pati ents referred from other medical units.















HMPMPS 7.75 2,145 73,625 29.1 100 4.6 5.6 27.4 
Netherlands 2 847 358,874 2.36 29 3.5 2.9 
Hong Kong 10 50 37,505 1.3 3 6 2 31 
Brazil 2 298 12,342 24.1 14 4.7 5 27.5 
Argenti na 2 242 30,052 8.1 5 2.0 2 31 
India 3 765 61,615 1.24 119 15.5
France 4 11,824 3,262,526 3.6 154 1.3 3 30.5 
Sudan 1 99 5,400 18.3 22 22.2 3.8 
South Africa 5 138 14,478 9.5 48 35 8 28 
HMPMPS: “Mónica Pretelini Sáenz” Maternal-Perinatal Hospital
 It is clear from this study that the main cause of admission in this study was 
hypertensive disorders, followed by haemorrhagic complicati ons; these outcomes are 
similar to those reported in Lati n American countries, like Argenti na and Brazil2, 7. By 
comparison, other studies report obstetric haemorrhage as the most common cause 
associated, like in Hong Kong and India6, 8. 
 Despite the worldwide variati on in the mortality rates, there is not a signifi cant 
variati on in the most common causes of admitt ance in the analysed studies, which 
includes hypertensive disorders and haemorrhage complicati ons. Parti cularly, in the case 
of Mexico undesirable changes can be expected in the rates of admission and mortality 
aft er this survey due to fi nancial reducti ons in the Health System that might compromise 
medical att enti on. 
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 In the follow-up period of this study, the MMR was signifi cantly lower than in 
other developing countries such as India and Sudan8, 9 but higher than high-income 
countries such as the Netherlands and France10, 11.
 Globally, maternal mortality has declined signifi cantly since 1990. While bett er 
access to emergency obstetrical care is parti ally responsible, women's empowerment 
might also be a contributi ng factor. Notwithstanding, over the last two decades, the MMR 
in the United States has doubled from 7.4/100,000 live births in 1986 to 14.5/100,000 
today. As a response to this trend, that country has added the obstetric criti cal care 
simulati on training12. The feasibility to introduce such training in other countries depends 
on the fi nancial resources, which may be compromised by economic dispariti es13.
 An analysis in Slovak Republic reduces the MMR points due to decrease in the 
caesarean secti on rate and episiotomy14. In the case of our insti tuti on, it is not probable 
to reach a signifi cant reducti on in cesarean secti ons in a short term of ti me as the pati ents 
belong to the group of risk pregnancies. Furthermore, a delay in the decision to perform 
a cesarean secti on in cases of prolonged vaginal deliveries could be detrimental for the 
maternal evoluti on15.
 In relati on to vital support, a total of 32.4% pati ents required MVS during their 
stay in the O-ICU, which was comparable to the rates from 20% to 30% reported by other 
groups2, 10. Of parti cular concern, the use of ECMO during pregnancy may be indicated in 
very select cases and should be delivered in centres with dedicated specialized units16. 
Unfortunately, our experience with only one pati ent restricts us to issue an enriching 
opinion. 
 Overall, the most common cause of pregnancy-related Acute Kidney Injury (AKI) 
in the O-ICU was eclampsia/HELLP syndrome (79/140, 56.4%), followed by chronic kidney 
disease exacerbati on (24/140, 17.1%). As such, 112 (80%) women were discharged with 
improvement, 24 (17.1%) died and four (2.9%) were transferred to an NHI in Mexico City. 
Adding to the above-menti oned informati on, in the studied populati on, the requirement 
of dialysis was similar to rate reported by a Brazilian study (8%)2 but considerably higher 
than in the Netherlands (1.9%)10. We suggest, therefore, that improving the quality of 
prenatal att enti on during pregnancy, paired with adequate management might help to 
reduce maternal morbidity and mortality related to AKI and this happens by making a 
correct evaluati on of kidney functi on17. Much att enti on has to be focused on the fact 
that in the O-ICU, 76.64% of all deaths were pati ents referred from other hospital units 
with a fatal outcome independent of the established treatment; and the main causes of 
mortality were septi c shock, followed by hypertensive complicati ons and hypovolemic 
shock. As has been published previously, a threshold ti me of 12-h with sepsis before 
getti  ng specialized medical att enti on, shows a good predicti ve value for maternal death 
and could be considered for evaluati ng the severity of complicated obstetrical pati ents18.
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 Because infecti ons, chronic hypertension, coagulopathies, and underlying proth-
romboti c conditi ons increase the risk of pregnancy-associated stroke (PAS) risk in women 
with preeclampsia, these women may warrant closer monitoring19. A very important aspect 
that cannot be omitt ed is the possible underdiagnosis of rare conditi ons or diseases that 
are not considered the fi rst cause of hospitalizati on such as Peripartum cardiomyopathy 
(PPCM)20.
 According to the Pearson test, the negati ve correlati on between platelets 
and MAP is to some extent expected if we think about the associati on between the 
main complicati ons of pregnancy responsible for the highest mortality in the world, 
preeclampsia/eclampsia and HELLP syndrome that would precisely explain a decrease in 
platelets with cases of hypertension.
 On the other hand, several early warning scores have been developed and propo- 
sed as a potenti al tool to reduce maternal morbidity and mortality, based on the identi -
fi cati on of predetermined abnormal values in the vital signs or laboratory parameters, to 
generate a rapid and eff ecti ve medical response21, 22.
 In Colombia, a country with similar characteristi cs to Mexico, Paternina-Caicedo 
et al23 evaluated through the area under the ROC curve (AUC) an Obstetric Early Warning 
Score in 702 obstetric admissions to criti cal care. The AUC of the score in conditi ons 
directly related to pregnancy and postpartum was 0.87 (95% confi dence interval, 0.79-
0.95), while in indirectly related conditi ons the AUC was 0.77 (95% confi dence interval, 
0.58-0.96). While further work is required to defi ne in detail the suitable variables for the 
constructi on of early warning scores in obstetrics, these scores may be a highly useful 
approach in the early identi fi cati on of women at an increased risk of dying.
 We cannot forget to menti on that the socioeconomic level and type of health 
insti tuti on might be a limitati on to extrapolate our results to richer countries and even to 
other health systems with more resources that also take care of wealthier people that live 
nearer to hospitals, than the poorest.
 From the analysis done, it can be concluded that the most consistent variables 
for a bad prognosis in the O-ICU are age, MAP, platelet and haemoglobin at admission; so 
special att enti on must be paid to fi nding the causes that compromise their normal levels 
in pregnant and postpartum women, and they may be the crucial elements to adjust 
the forecast scales for pregnant women. Proper management of O-ICU pati ents requires 
intensive and multi disciplinary cooperati on. 
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